Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamics of Minimal Residual Disease in Neuroblastoma Patients.
Uemura S, Ishida T, Thwin KKM, Yamamoto N, Tamura A, Kishimoto K, Hasegawa D, Kosaka Y, Nino N, Lin KS, Takafuji S, Mori T, Iijima K, Nishimura N. Uemura S, et al. Among authors: takafuji s. Front Oncol. 2019 Jun 4;9:455. doi: 10.3389/fonc.2019.00455. eCollection 2019. Front Oncol. 2019. PMID: 31214500 Free PMC article. Review.
Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood.
Lin KS, Uemura S, Thwin KKM, Nakatani N, Ishida T, Yamamoto N, Tamura A, Saito A, Mori T, Hasegawa D, Kosaka Y, Nino N, Nagano C, Takafuji S, Iijima K, Nishimura N. Lin KS, et al. Among authors: takafuji s. Transl Oncol. 2021 Aug;14(8):101019. doi: 10.1016/j.tranon.2021.101019. Epub 2021 May 14. Transl Oncol. 2021. PMID: 33993097 Free PMC article.
Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients.
Thwin KKM, Ishida T, Uemura S, Yamamoto N, Lin KS, Tamura A, Kozaki A, Saito A, Kishimoto K, Mori T, Hasegawa D, Kosaka Y, Nino N, Takafuji S, Iijima K, Nishimura N. Thwin KKM, et al. Among authors: takafuji s. J Mol Diagn. 2020 Feb;22(2):236-246. doi: 10.1016/j.jmoldx.2019.10.012. Epub 2019 Dec 16. J Mol Diagn. 2020. PMID: 31837427 Free article.
An infant with refractory cytomegalovirus-induced thrombocytopenia.
Uemura S, Mori T, Nino N, Sakakibara N, Takafuji S, Myojin S, Takami Y, Morioka I, Nishimura N, Kugo M, Iijima K. Uemura S, et al. Among authors: takafuji s. Clin Case Rep. 2019 Dec 17;8(1):75-78. doi: 10.1002/ccr3.2581. eCollection 2020 Jan. Clin Case Rep. 2019. PMID: 31998491 Free PMC article.
Retrospective analysis of high-dose chemotherapy followed by autologous stem cell transplantation for high-risk pediatric osteosarcoma.
Uemura S, Mori T, Ishiko S, Takafuji S, Nino N, Yamamoto N, Hayakawa A, Nishimura N, Hara H, Kawamoto T, Akisue T, Iijima K. Uemura S, et al. Among authors: takafuji s. Pediatr Hematol Oncol. 2020 May;37(4):337-343. doi: 10.1080/08880018.2020.1729906. Epub 2020 Mar 10. Pediatr Hematol Oncol. 2020. PMID: 32151185 Clinical Trial.
Successful Treatment of Transplantation-associated Atypical Hemolytic Uremic Syndrome With Eculizumab.
Hasegawa D, Saito A, Nino N, Uemura S, Takafuji S, Yokoi T, Kozaki A, Ishida T, Kawasaki K, Yasumi T, Sakata N, Ohtsuka Y, Hirase S, Mori T, Nishimura N, Kusumoto M, Ogawa Y, Tominaga K, Nakagawa T, Kanda K, Tanaka R, Kosaka Y. Hasegawa D, et al. Among authors: takafuji s. J Pediatr Hematol Oncol. 2018 Jan;40(1):e41-e44. doi: 10.1097/MPH.0000000000000862. J Pediatr Hematol Oncol. 2018. PMID: 28538511
ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
Uemura S, Nishimura N, Hasegawa D, Shono A, Sakaguchi K, Matsumoto H, Nakamachi Y, Saegusa J, Yokoi T, Tahara T, Tamura A, Yamamoto N, Saito A, Kozaki A, Kishimoto K, Ishida T, Nino N, Takafuji S, Mori T, Iijima K, Kosaka Y. Uemura S, et al. Among authors: takafuji s. Int J Hematol. 2018 May;107(5):604-609. doi: 10.1007/s12185-017-2371-5. Epub 2017 Nov 24. Int J Hematol. 2018. PMID: 29177615
Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients.
Uemura S, Lin KS, Mon Thwin KK, Nakatani N, Ishida T, Yamamoto N, Tamura A, Saito A, Mori T, Hasegawa D, Kosaka Y, Nino N, Nagano C, Takafuji S, Iijima K, Nishimura N. Uemura S, et al. Among authors: takafuji s. Mol Clin Oncol. 2021 Jul;15(1):137. doi: 10.3892/mco.2021.2299. Epub 2021 May 19. Mol Clin Oncol. 2021. PMID: 34055352 Free PMC article.
40 results